Latest news
LH Maintained by Piper Sandler -- Price Target Raised to $309 - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:56:10 GMTLH Maintained by JP Morgan -- Price Target Raised to $360 - GuruFocusGuruFocus · Mon, 03 Aug 2026 17:31:38 GMTLH Maintains Overweight Rating by Morgan Stanley -- Price Target Raised to $338 - GuruFocusGuruFocus · Fri, 31 Jul 2026 19:58:31 GMTAnalysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Cytokinetics (CYTK) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 15:46:00 GMTLH Maintained by Barclays -- Price Target Raised to $320 - GuruFocusGuruFocus · Fri, 31 Jul 2026 14:56:28 GMTTruist Financial Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $350 - MoomooMoomoo · Fri, 31 Jul 2026 13:31:00 GMTLH: Q2 2026 revenue rose 5.8% to $3.73B, with net earnings up 25% and strong segment margins - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT